nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.164	0.206	CbGbCtD
Saxagliptin—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.118	0.149	CbGbCtD
Saxagliptin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.101	0.127	CbGbCtD
Saxagliptin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0923	0.116	CbGbCtD
Saxagliptin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0813	0.102	CbGbCtD
Saxagliptin—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.063	0.0793	CbGbCtD
Saxagliptin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0373	0.047	CbGbCtD
Saxagliptin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0342	0.0431	CbGbCtD
Saxagliptin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0341	0.043	CbGbCtD
Saxagliptin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0317	0.04	CbGbCtD
Saxagliptin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0146	0.0183	CbGbCtD
Saxagliptin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0133	0.0168	CbGbCtD
Saxagliptin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0091	0.0115	CbGbCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000718	0.00348	CcSEcCtD
Saxagliptin—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000713	0.00346	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000708	0.00344	CcSEcCtD
Saxagliptin—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000698	0.00339	CcSEcCtD
Saxagliptin—Infection—Topotecan—peripheral nervous system neoplasm	0.000694	0.00337	CcSEcCtD
Saxagliptin—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000693	0.00336	CcSEcCtD
Saxagliptin—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000693	0.00336	CcSEcCtD
Saxagliptin—Infection—Tretinoin—peripheral nervous system neoplasm	0.000688	0.00334	CcSEcCtD
Saxagliptin—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000688	0.00334	CcSEcCtD
Saxagliptin—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000684	0.00332	CcSEcCtD
Saxagliptin—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000684	0.00332	CcSEcCtD
Saxagliptin—Infection—Melphalan—peripheral nervous system neoplasm	0.000679	0.0033	CcSEcCtD
Saxagliptin—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000678	0.00329	CcSEcCtD
Saxagliptin—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000678	0.00329	CcSEcCtD
Saxagliptin—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000678	0.00329	CcSEcCtD
Saxagliptin—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000673	0.00326	CcSEcCtD
Saxagliptin—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000673	0.00326	CcSEcCtD
Saxagliptin—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00067	0.00325	CcSEcCtD
Saxagliptin—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000664	0.00322	CcSEcCtD
Saxagliptin—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000643	0.00312	CcSEcCtD
Saxagliptin—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.000643	0.00312	CcSEcCtD
Saxagliptin—Infestation—Etoposide—peripheral nervous system neoplasm	0.000643	0.00312	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000636	0.00309	CcSEcCtD
Saxagliptin—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.000634	0.00307	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000631	0.00306	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000631	0.00306	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000623	0.00302	CcSEcCtD
Saxagliptin—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000615	0.00298	CcSEcCtD
Saxagliptin—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00061	0.00296	CcSEcCtD
Saxagliptin—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00061	0.00296	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000603	0.00292	CcSEcCtD
Saxagliptin—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000602	0.00292	CcSEcCtD
Saxagliptin—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000602	0.00292	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000598	0.0029	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000598	0.0029	CcSEcCtD
Saxagliptin—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000597	0.0029	CcSEcCtD
Saxagliptin—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000597	0.0029	CcSEcCtD
Saxagliptin—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000591	0.00287	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00059	0.00286	CcSEcCtD
Saxagliptin—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00059	0.00286	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000571	0.00277	CcSEcCtD
Saxagliptin—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000569	0.00276	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000566	0.00275	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000566	0.00275	CcSEcCtD
Saxagliptin—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000563	0.00273	CcSEcCtD
Saxagliptin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000555	0.00269	CcSEcCtD
Saxagliptin—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000554	0.00269	CcSEcCtD
Saxagliptin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000552	0.00268	CcSEcCtD
Saxagliptin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00055	0.00267	CcSEcCtD
Saxagliptin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00055	0.00267	CcSEcCtD
Saxagliptin—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000548	0.00266	CcSEcCtD
Saxagliptin—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000548	0.00266	CcSEcCtD
Saxagliptin—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000548	0.00266	CcSEcCtD
Saxagliptin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000548	0.00266	CcSEcCtD
Saxagliptin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000548	0.00266	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000544	0.00264	CcSEcCtD
Saxagliptin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000543	0.00263	CcSEcCtD
Saxagliptin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00054	0.00262	CcSEcCtD
Saxagliptin—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000528	0.00256	CcSEcCtD
Saxagliptin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000525	0.00255	CcSEcCtD
Saxagliptin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000522	0.00253	CcSEcCtD
Saxagliptin—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000521	0.00253	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000516	0.0025	CcSEcCtD
Saxagliptin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000515	0.0025	CcSEcCtD
Saxagliptin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000514	0.00249	CcSEcCtD
Saxagliptin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00051	0.00248	CcSEcCtD
Saxagliptin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00051	0.00248	CcSEcCtD
Saxagliptin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00051	0.00247	CcSEcCtD
Saxagliptin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000506	0.00245	CcSEcCtD
Saxagliptin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000504	0.00244	CcSEcCtD
Saxagliptin—Infection—Vincristine—peripheral nervous system neoplasm	0.000503	0.00244	CcSEcCtD
Saxagliptin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000501	0.00243	CcSEcCtD
Saxagliptin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000497	0.00241	CcSEcCtD
Saxagliptin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000497	0.00241	CcSEcCtD
Saxagliptin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000495	0.0024	CcSEcCtD
Saxagliptin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000494	0.0024	CcSEcCtD
Saxagliptin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000491	0.00238	CcSEcCtD
Saxagliptin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00049	0.00238	CcSEcCtD
Saxagliptin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00049	0.00238	CcSEcCtD
Saxagliptin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000488	0.00237	CcSEcCtD
Saxagliptin—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000485	0.00235	CcSEcCtD
Saxagliptin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000484	0.00235	CcSEcCtD
Saxagliptin—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000479	0.00232	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000478	0.00232	CcSEcCtD
Saxagliptin—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000467	0.00226	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000463	0.00225	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000463	0.00225	CcSEcCtD
Saxagliptin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.00224	CcSEcCtD
Saxagliptin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000462	0.00224	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000461	0.00224	CcSEcCtD
Saxagliptin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000458	0.00222	CcSEcCtD
Saxagliptin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000458	0.00222	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.0022	CcSEcCtD
Saxagliptin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.0022	CcSEcCtD
Saxagliptin—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000451	0.00219	CcSEcCtD
Saxagliptin—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.00218	CcSEcCtD
Saxagliptin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000448	0.00217	CcSEcCtD
Saxagliptin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000447	0.00217	CcSEcCtD
Saxagliptin—Infection—Cisplatin—peripheral nervous system neoplasm	0.000444	0.00216	CcSEcCtD
Saxagliptin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000444	0.00215	CcSEcCtD
Saxagliptin—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.00215	CcSEcCtD
Saxagliptin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00044	0.00214	CcSEcCtD
Saxagliptin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00044	0.00214	CcSEcCtD
Saxagliptin—Rash—Topotecan—peripheral nervous system neoplasm	0.00044	0.00214	CcSEcCtD
Saxagliptin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00044	0.00213	CcSEcCtD
Saxagliptin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000438	0.00212	CcSEcCtD
Saxagliptin—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000438	0.00212	CcSEcCtD
Saxagliptin—Headache—Topotecan—peripheral nervous system neoplasm	0.000437	0.00212	CcSEcCtD
Saxagliptin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000437	0.00212	CcSEcCtD
Saxagliptin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000437	0.00212	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000437	0.00212	CcSEcCtD
Saxagliptin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000436	0.00212	CcSEcCtD
Saxagliptin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000436	0.00212	CcSEcCtD
Saxagliptin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000436	0.00212	CcSEcCtD
Saxagliptin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000435	0.00211	CcSEcCtD
Saxagliptin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000435	0.00211	CcSEcCtD
Saxagliptin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000434	0.00211	CcSEcCtD
Saxagliptin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000434	0.00211	CcSEcCtD
Saxagliptin—Rash—Melphalan—peripheral nervous system neoplasm	0.000431	0.00209	CcSEcCtD
Saxagliptin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000431	0.00209	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.00208	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000425	0.00206	CcSEcCtD
Saxagliptin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000418	0.00203	CcSEcCtD
Saxagliptin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.00203	CcSEcCtD
Saxagliptin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000417	0.00202	CcSEcCtD
Saxagliptin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000417	0.00202	CcSEcCtD
Saxagliptin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.00201	CcSEcCtD
Saxagliptin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000415	0.00201	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000414	0.00201	CcSEcCtD
Saxagliptin—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000414	0.00201	CcSEcCtD
Saxagliptin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000411	0.002	CcSEcCtD
Saxagliptin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000411	0.002	CcSEcCtD
Saxagliptin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00041	0.00199	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000408	0.00198	CcSEcCtD
Saxagliptin—Infection—Etoposide—peripheral nervous system neoplasm	0.000407	0.00197	CcSEcCtD
Saxagliptin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000406	0.00197	CcSEcCtD
Saxagliptin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000406	0.00197	CcSEcCtD
Saxagliptin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.00197	CcSEcCtD
Saxagliptin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000401	0.00195	CcSEcCtD
Saxagliptin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.0004	0.00194	CcSEcCtD
Saxagliptin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000398	0.00193	CcSEcCtD
Saxagliptin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000396	0.00192	CcSEcCtD
Saxagliptin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000387	0.00188	CcSEcCtD
Saxagliptin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.00188	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000386	0.00187	CcSEcCtD
Saxagliptin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.00186	CcSEcCtD
Saxagliptin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000377	0.00183	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000375	0.00182	CcSEcCtD
Saxagliptin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000373	0.00181	CcSEcCtD
Saxagliptin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.0018	CcSEcCtD
Saxagliptin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.00178	CcSEcCtD
Saxagliptin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000363	0.00176	CcSEcCtD
Saxagliptin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00036	0.00175	CcSEcCtD
Saxagliptin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00036	0.00175	CcSEcCtD
Saxagliptin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00036	0.00175	CcSEcCtD
Saxagliptin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000357	0.00173	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000354	0.00172	CcSEcCtD
Saxagliptin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000353	0.00171	CcSEcCtD
Saxagliptin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00035	0.0017	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.00169	CcSEcCtD
Saxagliptin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.00168	CcSEcCtD
Saxagliptin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000338	0.00164	CcSEcCtD
Saxagliptin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000336	0.00163	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000335	0.00163	CcSEcCtD
Saxagliptin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000335	0.00162	CcSEcCtD
Saxagliptin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000334	0.00162	CcSEcCtD
Saxagliptin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.00162	CcSEcCtD
Saxagliptin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.00162	CcSEcCtD
Saxagliptin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.00161	CcSEcCtD
Saxagliptin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.0016	CcSEcCtD
Saxagliptin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00033	0.0016	CcSEcCtD
Saxagliptin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.0016	CcSEcCtD
Saxagliptin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000326	0.00158	CcSEcCtD
Saxagliptin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000324	0.00157	CcSEcCtD
Saxagliptin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.00157	CcSEcCtD
Saxagliptin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000322	0.00156	CcSEcCtD
Saxagliptin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000321	0.00156	CcSEcCtD
Saxagliptin—Rash—Vincristine—peripheral nervous system neoplasm	0.000319	0.00155	CcSEcCtD
Saxagliptin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000319	0.00155	CcSEcCtD
Saxagliptin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00155	CcSEcCtD
Saxagliptin—Headache—Vincristine—peripheral nervous system neoplasm	0.000317	0.00154	CcSEcCtD
Saxagliptin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.00152	CcSEcCtD
Saxagliptin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.00151	CcSEcCtD
Saxagliptin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000302	0.00146	CcSEcCtD
Saxagliptin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000301	0.00146	CcSEcCtD
Saxagliptin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.00143	CcSEcCtD
Saxagliptin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000294	0.00143	CcSEcCtD
Saxagliptin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00142	CcSEcCtD
Saxagliptin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00029	0.00141	CcSEcCtD
Saxagliptin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000284	0.00138	CcSEcCtD
Saxagliptin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00137	CcSEcCtD
Saxagliptin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00137	CcSEcCtD
Saxagliptin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000281	0.00137	CcSEcCtD
Saxagliptin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00135	CcSEcCtD
Saxagliptin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000271	0.00131	CcSEcCtD
Saxagliptin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00131	CcSEcCtD
Saxagliptin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000266	0.00129	CcSEcCtD
Saxagliptin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000261	0.00126	CcSEcCtD
Saxagliptin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00126	CcSEcCtD
Saxagliptin—Rash—Etoposide—peripheral nervous system neoplasm	0.000258	0.00125	CcSEcCtD
Saxagliptin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000258	0.00125	CcSEcCtD
Saxagliptin—Headache—Etoposide—peripheral nervous system neoplasm	0.000257	0.00125	CcSEcCtD
Saxagliptin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.00124	CcSEcCtD
Saxagliptin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000243	0.00118	CcSEcCtD
Saxagliptin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00116	CcSEcCtD
Saxagliptin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00116	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000238	0.00115	CcSEcCtD
Saxagliptin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00023	0.00111	CcSEcCtD
Saxagliptin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000228	0.00111	CcSEcCtD
Saxagliptin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.00109	CcSEcCtD
Saxagliptin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00108	CcSEcCtD
Saxagliptin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.00108	CcSEcCtD
Saxagliptin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.00108	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00107	CcSEcCtD
Saxagliptin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.00103	CcSEcCtD
Saxagliptin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.00102	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00102	CcSEcCtD
Saxagliptin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00101	CcSEcCtD
Saxagliptin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.001	CcSEcCtD
Saxagliptin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000981	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000962	CcSEcCtD
Saxagliptin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000961	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000939	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000911	CcSEcCtD
Saxagliptin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000908	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00089	CcSEcCtD
Saxagliptin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000889	CcSEcCtD
Saxagliptin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000885	CcSEcCtD
Saxagliptin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000881	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000843	CcSEcCtD
Saxagliptin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000821	CcSEcCtD
Saxagliptin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000819	CcSEcCtD
Saxagliptin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000815	CcSEcCtD
Saxagliptin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000799	CcSEcCtD
Saxagliptin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000788	CcSEcCtD
Saxagliptin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.00076	CcSEcCtD
Saxagliptin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00074	CcSEcCtD
Saxagliptin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000737	CcSEcCtD
Saxagliptin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000729	CcSEcCtD
Saxagliptin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000708	CcSEcCtD
Saxagliptin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000703	CcSEcCtD
Saxagliptin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000702	CcSEcCtD
Saxagliptin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000698	CcSEcCtD
Saxagliptin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000682	CcSEcCtD
Saxagliptin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000662	CcSEcCtD
Saxagliptin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000656	CcSEcCtD
Saxagliptin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00065	CcSEcCtD
Saxagliptin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000649	CcSEcCtD
Saxagliptin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000646	CcSEcCtD
Saxagliptin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000612	CcSEcCtD
